C([N:4]1[CH2:13][C:12]([CH3:15])([CH3:14])[C:11]2[C:6](=[CH:7][C:8]([NH:16][C:17](=[O:35])[C:18]3[CH:23]=[CH:22][CH:21]=[N:20][C:19]=3[NH:24][CH2:25][C:26]3[N:31]=[C:30]4[NH:32][CH:33]=[CH:34][C:29]4=[CH:28][CH:27]=3)=[CH:9][CH:10]=2)[CH2:5]1)(=O)C.Cl.C([O-])(O)=O.[Na+]>CCO>[CH3:14][C:12]1([CH3:15])[C:11]2[C:6](=[CH:7][C:8]([NH:16][C:17](=[O:35])[C:18]3[CH:23]=[CH:22][CH:21]=[N:20][C:19]=3[NH:24][CH2:25][C:26]3[N:31]=[C:30]4[NH:32][CH:33]=[CH:34][C:29]4=[CH:28][CH:27]=3)=[CH:9][CH:10]=2)[CH2:5][NH:4][CH2:13]1N-(2-Acetyl-4,4-dimethyl-1,2,3,4-tetrahydro-isoquinolin-7-yl)-2-[(1H-pyrrolo[2,3-b]pyridin-6-ylmethyl)amino]nicotinamide (0.180 g, 0.384 mmol, Example 2) was dissolved into 10 mL of EtOH and 5 mL of concentrated HCl was added. The mixture was heated to 75° C. for 4 days. The volume was reduced to ⅓. Sat'd. NaHCO3 was added until the solution became cloudy. The aqueous phase was extracted with CH2Cl2 and the combined organic phases were dried over Na2SO4, filtered and concentrated to give a brown residue. The residue was purified by HPLC (Beckman) to afford the title compound. MS (ES+): 427 (M+H). Calc'd. for C25H26N6O—426.52.
読み込み中…